BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9003146)

  • 1. Using social gatherings to encourage HIV risk reduction among drug users.
    Wood M; Rhodes F
    Am J Public Health; 1996 Dec; 86(12):1815-6. PubMed ID: 9003146
    [No Abstract]   [Full Text] [Related]  

  • 2. Postscript: where do we go from here?
    Sloboda Z; Stephens RC; Alemagno S
    J Psychoactive Drugs; 1998; 30(3):307-14. PubMed ID: 9798797
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the HIV risk reduction intervention for women entering inpatient substance abuse treatment.
    Eldridge GD; St Lawrence JS; Little CE; Shelby MC; Brasfield TL; Service JW; Sly K
    AIDS Educ Prev; 1997 Feb; 9(1 Suppl):62-76. PubMed ID: 9083599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention.
    Broadhead RS; Heckathorn DD; Weakliem DL; Anthony DL; Madray H; Mills RJ; Hughes J
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):42-57. PubMed ID: 9722809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks.
    Latkin CA
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):151-9. PubMed ID: 9722820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of HIV risk reduction initiatives among out-of-treatment non-injection drug users.
    Cottler LB; Leukefeld C; Hoffman J; Desmond D; Wechsberg W; Inciardi JA; Compton WM; Ben Abdallah A; Cunningham-Williams R; Woodson S
    J Psychoactive Drugs; 1998; 30(3):279-90. PubMed ID: 9798794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug abuse aspects of HIV/AIDS and other infections.
    AIDS Read; 2001 Feb; 11(2):84. PubMed ID: 11279883
    [No Abstract]   [Full Text] [Related]  

  • 8. Substance abuse and HIV infection.
    Ferrando SJ; Batki SL
    New Dir Ment Health Serv; 2000; (87):57-67. PubMed ID: 11031802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV prevention and psychoactive drug use: a research agenda.
    Des Jarlais DC; Semaan S
    J Epidemiol Community Health; 2009 Mar; 63(3):191-6. PubMed ID: 19218258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faces of HIV/AIDS and substance abuse in Native American communities.
    Saylors K; Jim N; Plasencia AV; Smith D
    J Psychoactive Drugs; 2005 Sep; 37(3):241-6. PubMed ID: 16295006
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of a HIV risk reduction education program among injection drug users in Puerto Rico.
    Colón HM; Robles RR; Freeman D; Matos T
    P R Health Sci J; 1993 Apr; 12(1):27-34. PubMed ID: 8511243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outreach-based HIV prevention for injecting drug users: a review of published outcome data.
    Coyle SL; Needle RH; Normand J
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):19-30. PubMed ID: 9722807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bringing Female Substance Users to the Center of the Global HIV Response.
    El-Bassel N; Strathdee SA
    J Acquir Immune Defic Syndr; 2015 Jun; 69 Suppl 2():S94-5. PubMed ID: 25978488
    [No Abstract]   [Full Text] [Related]  

  • 14. Expanded syringe access demonstration program in New York State: an intervention to prevent HIV/AIDS transmission.
    Klein SJ; Birkhead GS; Candelas AR
    J Urban Health; 2000 Dec; 77(4):762-7. PubMed ID: 11194315
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV prevention protocols: adaptation to evolving trends in drug use.
    Wechsberg WM; Desmond D; Inciardi JA; Leukefeld CG; Cottler LB; Hoffman J
    J Psychoactive Drugs; 1998; 30(3):291-8. PubMed ID: 9798795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV serostatus as a function of drug treatment setting.
    Klahn JA; Fisher DG; Wood JL
    J Acquir Immune Defic Syndr; 2001 Nov; 28(3):308. PubMed ID: 11694844
    [No Abstract]   [Full Text] [Related]  

  • 17. [HIV infection and risk behavior among drug users served by a program of syringe exchange].
    Bravo MJ; Colomo C; Barrio G; de la Fuente L
    Med Clin (Barc); 1994 May; 102(18):719. PubMed ID: 8028429
    [No Abstract]   [Full Text] [Related]  

  • 18. Editors' introduction: HIV/AIDS interventions for out-of-treatment drug users.
    Inciardi JA; Needle RH
    J Psychoactive Drugs; 1998; 30(3):225-9. PubMed ID: 9798787
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV sexual risk reduction intervention with heterosexual men.
    Seal DW; Exner TM; Ehrhardt AA
    Arch Intern Med; 2003 Mar; 163(6):738-9. PubMed ID: 12639212
    [No Abstract]   [Full Text] [Related]  

  • 20. Tenofovir helps prevent HIV in drug users.
    BMJ; 2013 Jun; 346():f3871. PubMed ID: 23777811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.